Bin Shao

2.1k total citations
48 papers, 777 citations indexed

About

Bin Shao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Bin Shao has authored 48 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Bin Shao's work include HER2/EGFR in Cancer Research (13 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Bin Shao is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Advanced Breast Cancer Therapies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Bin Shao collaborates with scholars based in China, Ethiopia and United States. Bin Shao's co-authors include Huiping Li, Ran Ran, Xiaoran Liu, Chia-Wei Li, Li-Chuan Chan, Jung-Mao Hsu, Mien‐Chie Hung, Linlin Sun, Yun‐Ju Lai and Guohong Song and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Bin Shao

47 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Shao China 17 424 310 215 155 139 48 777
Cristina Nieto‐Jiménez Spain 16 464 1.1× 456 1.5× 137 0.6× 181 1.2× 139 1.0× 40 942
Vasilios Liapis Australia 17 270 0.6× 303 1.0× 124 0.6× 145 0.9× 98 0.7× 30 672
Kazumasa Minami Japan 15 321 0.8× 262 0.8× 131 0.6× 154 1.0× 215 1.5× 55 758
Abhijit Aithal United States 12 372 0.9× 428 1.4× 163 0.8× 218 1.4× 94 0.7× 23 809
Verena Stresing France 12 432 1.0× 390 1.3× 170 0.8× 123 0.8× 179 1.3× 14 919
Keyu Li China 17 276 0.7× 360 1.2× 179 0.8× 184 1.2× 71 0.5× 54 762
Jennifer Sims‐Mourtada United States 16 529 1.2× 515 1.7× 153 0.7× 113 0.7× 132 0.9× 34 1.0k

Countries citing papers authored by Bin Shao

Since Specialization
Citations

This map shows the geographic impact of Bin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Shao more than expected).

Fields of papers citing papers by Bin Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Shao. The network helps show where Bin Shao may publish in the future.

Co-authorship network of co-authors of Bin Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Shao. A scholar is included among the top collaborators of Bin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Shao. Bin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Bin, et al.. (2025). A Novel Circ_0004104/MiR‐493‐5p/SYPL1 Cascade Contributes to Colorectal Cancer Progression. Journal of Biochemical and Molecular Toxicology. 39(4). e70226–e70226. 1 indexed citations
2.
Shao, Bin, et al.. (2025). Combining with immunotherapy is an emerging trend for local treatment of colorectal cancer liver metastases: a bibliometric analysis. Frontiers in Oncology. 15. 1490570–1490570. 2 indexed citations
3.
Wang, Nan, Xiaoran Liu, Ying Yan, et al.. (2024). HER2 status results in an unstable switch from primary to recurrent breast cancer. Neoplasma. 71(4). 392–401. 1 indexed citations
4.
Jiang, Hanfang, et al.. (2024). Variant allele frequency in circulating tumor DNA correlated with tumor disease burden and predicted outcomes in patients with advanced breast cancer. Breast Cancer Research and Treatment. 204(3). 617–629. 4 indexed citations
5.
Jiang, Hanfang, Huiping Li, Guohong Song, et al.. (2023). Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study. Breast Cancer Research and Treatment. 199(1). 67–79. 5 indexed citations
6.
Zhang, Ruyan, Yifei Chen, Xiaoran Liu, et al.. (2023). Efficacy of apatinib 250 mg combined with chemotherapy in patients with pretreated advanced breast cancer in a real-world setting. Frontiers in Oncology. 13. 1076469–1076469. 2 indexed citations
7.
8.
Zheng, Tiantian, Xiaoran Liu, Bin Shao, et al.. (2022). Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of Translational Medicine. 20(1). 211–211. 12 indexed citations
9.
Zhang, Qingyuan, Bin Shao, Zhongsheng Tong, et al.. (2022). A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer. BMC Medicine. 20(1). 321–321. 24 indexed citations
10.
Wang, Mengting, Yaxin Liu, Bin Shao, et al.. (2022). HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment. Frontiers in Bioengineering and Biotechnology. 10. 1015295–1015295. 9 indexed citations
11.
Zhang, Ruyan, Xiaoran Liu, Bin Shao, et al.. (2021). Clinicopathological features and prognosis of patients with pregnancy‐associated breast cancer: A matched case control study. Asia-Pacific Journal of Clinical Oncology. 17(4). 396–402. 9 indexed citations
12.
Jiang, Hanfang, Ruyan Zhang, Xiaoran Liu, et al.. (2021). Bilateral breast cancer in China: A 10‐year single‐center retrospective study (2006–2016). Cancer Medicine. 10(17). 6089–6098. 6 indexed citations
13.
Li, Yi, Yixuan Qiu, Huihui Li, et al.. (2021). Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study. Frontiers in Oncology. 11. 664429–664429. 27 indexed citations
14.
Zhang, Bin, Liangbin Wang, Zhixian Liu, et al.. (2020). Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer. Medicine. 99(25). e20617–e20617. 4 indexed citations
15.
16.
Ran, Ran, et al.. (2019). Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis. Breast Cancer Research and Treatment. 178(1). 17–33. 78 indexed citations
17.
Li, Huiping, Jiang Liu, Jianing Chen, et al.. (2018). A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients. Nature Communications. 9(1). 1614–1614. 84 indexed citations
18.
19.
Li, Huiping, Bin Shao, Guohong Song, et al.. (2016). Efficacy and safety of trastuzumab combined with chemotherapy for first-line treatment and beyond progression of HER2-overexpressing advanced breast cancer. Chinese Journal of Cancer Research. 28(3). 330–338. 16 indexed citations
20.
Liang, Xu, Jie Zhang, Xinna Zhou, et al.. (2012). Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients. Clinical & Translational Oncology. 15(4). 331–334. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Nieto‐Jiménez Breakdown of academic impact, for papers by Vasilios Liapis Breakdown of academic impact, for papers by Kazumasa Minami Breakdown of academic impact, for papers by Abhijit Aithal Breakdown of academic impact, for papers by Verena Stresing Breakdown of academic impact, for papers by Keyu Li Breakdown of academic impact, for papers by Jennifer Sims‐Mourtada
Rankless by CCL
2026